SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab reports 93% fall in Q3 net profit

14 Nov 2013 Evaluate

Strides Arcolab has reported results for the third quarter ended September 30, 2013.

The company has reported 92.66% fall in its net profit at Rs 2.21 crore for the quarter as compared to Rs 30.11 crore for the same quarter in the previous year. However, total income of the company has increased by 13.59% at Rs 225.46 crore for quarter under review as compared to Rs 198.48 crore for the quarter ended September 30, 2012.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

1000.65 4.30 (0.43%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×